Emerald Advisers, LLC Blueprint Medicines Corp Transaction History

Emerald Advisers, LLC

$2.35 Billion
Q4 2024

A detailed history of Emerald Advisers, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Emerald Advisers, LLC holds 416,866 shares of BPMC stock, worth $38 Million. This represents 1.55% of its overall portfolio holdings.

Number of Shares

416,866

Previous 375,866 10.91%

Holding current value

$38 Million

Previous $34.8 Million 4.62%

% of portfolio

1.55%

Previous 1.44%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$82.48 - $101.39 $3.38 Million - $4.16 Million	41,000 Added 10.91%	416,866 $36.4 Million
Q3 2024 Oct 29, 2024	BUY	$84.1 - $120.5 $2.92 Million - $4.18 Million	34,666 Added 10.16%	375,866 $34.8 Million
Q2 2024 Aug 06, 2024	SELL	$85.18 - $108.78 $5.26 Million - $6.71 Million	-61,710 Reduced 15.32%	341,200 $36.8 Million
Q1 2024 May 08, 2024	SELL	$73.17 - $99.79 $4.65 Million - $6.34 Million	-63,516 Reduced 13.62%	402,910 $38.2 Million
Q4 2023 Feb 05, 2024	SELL	$43.96 - $92.84 $6.18 Million - $13.1 Million	-140,611 Reduced 23.16%	466,426 $43 Million
Q3 2023 Oct 26, 2023	BUY	$46.9 - $66.0 $5.21 Million - $7.32 Million	110,984 Added 22.37%	607,037 $30.5 Million
Q2 2023 Jul 25, 2023	BUY	$42.2 - $66.37 $2.44 Million - $3.84 Million	57,804 Added 13.19%	496,053 $31.4 Million
Q1 2023 May 04, 2023	BUY	$37.97 - $50.0 $1.79 Million - $2.35 Million	47,093 Added 12.04%	438,249 $19.7 Million
Q4 2022 Feb 03, 2023	BUY	$41.06 - $66.48 $2.98 Million - $4.83 Million	72,582 Added 22.78%	391,156 $17.1 Million
Q3 2022 Oct 25, 2022	BUY	$49.93 - $77.7 $15.9 Million - $24.8 Million	318,574 New	318,574 $21 Million
Q1 2022 Apr 29, 2022	SELL	$54.1 - $110.08 $9.18 Million - $18.7 Million	-169,659 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$94.25 - $115.99 $6.02 Million - $7.41 Million	-63,849 Reduced 27.34%	169,659 $18.2 Million
Q3 2021 Oct 28, 2021	BUY	$80.98 - $109.47 $580,869 - $785,228	7,173 Added 3.17%	233,508 $24 Million
Q2 2021 Jul 29, 2021	SELL	$82.78 - $101.0 $2.8 Million - $3.41 Million	-33,799 Reduced 12.99%	226,335 $19.9 Million
Q1 2021 Apr 29, 2021	SELL	$90.71 - $108.28 $3.43 Million - $4.09 Million	-37,771 Reduced 12.68%	260,134 $25.3 Million
Q4 2020 Jan 29, 2021	SELL	$92.08 - $124.48 $7.61 Million - $10.3 Million	-82,684 Reduced 21.73%	297,905 $33.4 Million
Q3 2020 Oct 28, 2020	SELL	$66.45 - $92.7 $989,839 - $1.38 Million	-14,896 Reduced 3.77%	380,589 $35.3 Million
Q2 2020 Jul 28, 2020	SELL	$57.09 - $79.27 $1.18 Million - $1.64 Million	-20,681 Reduced 4.97%	395,485 $30.8 Million
Q1 2020 Apr 30, 2020	BUY	$48.11 - $82.22 $20 Million - $34.2 Million	416,166 New	416,166 $24.3 Million

Others Institutions Holding BPMC

# of Institutions

380

Shares Held

65.9M

Call Options Held

1.6M

Put Options Held

1.41M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.45B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.

Account

Emerald Advisers, LLC Blueprint Medicines Corp Transaction History